Synova Life Sciences
Pre-clinicalAdipocytes obtained through the Synova WAVE process stained with Calcein AM and DAPI showing healthy metabolic activity and high viability. Viability was 91.2% median, 90.2% mean, with a standard deviation of 2.6%
Founded
2019
Focus
OncologyCell Therapy
About
Adipocytes obtained through the Synova WAVE process stained with Calcein AM and DAPI showing healthy metabolic activity and high viability. Viability was 91.2% median, 90.2% mean, with a standard deviation of 2.6%
Company Info
TypePrivate
Founded2019
LocationNew York, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile